Salmonella typhi Ty21a live antigen is a live attenuated vaccine for oral administration only. It contains the attenuated strain Salmonella typhi Ty21a. The vaccine prevents the development of typhoid fever, an acute, febrile enteric disease caused by Salmonella typhi by inducing a local immune response in the intestinal tract.
Stanford LPCH Vaccine Program, Stanford, California, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.